| 发明名称 |
TACI-immunoglobulinfusionsproteiner |
| 摘要 |
<p>Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand, such as a soluble receptor, have proven usefulness in both basic research and as therapeutics. The present invention provides improved soluble transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptors.</p> |
| 申请公布号 |
DK2116259(T3) |
申请公布日期 |
2012.05.21 |
| 申请号 |
DK20090168970T |
申请日期 |
2002.05.20 |
| 申请人 |
ZYMOGENETICS, INC. |
发明人 |
RIXON, MARK W;GROSS, JANE A |
| 分类号 |
A61K39/395;C12N15/09;A61K38/00;A61K48/00;A61P35/00;C07K14/705;C07K14/715;C07K16/00;C07K19/00 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
